Seres Therapeutics, Inc. Increase (Decrease) in Restricted Cash
Seres Therapeutics, Inc. (MCRB) reported Increase (Decrease) in Restricted Cash of $113.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2018-03-08
- Seres Therapeutics, Inc. increase (decrease) in restricted cash for the quarter ending 2017-12-31 was $0.00.
- Seres Therapeutics, Inc. increase (decrease) in restricted cash for the quarter ending 2017-09-30 was $0.00.
- Seres Therapeutics, Inc. increase (decrease) in restricted cash for the quarter ending 2017-06-30 was $112.00K.
- Seres Therapeutics, Inc. increase (decrease) in restricted cash for the quarter ending 2017-03-31 was $1.00K, a 0.00% change year-over-year.
- Seres Therapeutics, Inc. increase (decrease) in restricted cash for fiscal 2017 was $113.00K.
- Seres Therapeutics, Inc. increase (decrease) in restricted cash for fiscal 2016 was -$139.00K, a 109.93% decline from fiscal 2015.
- Seres Therapeutics, Inc. increase (decrease) in restricted cash for fiscal 2015 was $1.40M, a 1272.55% increase from fiscal 2014.
- Seres Therapeutics, Inc. increase (decrease) in restricted cash for fiscal 2014 was $102.00K, a 920.00% increase from fiscal 2013.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $0.00 derived: sum of 2 quarters · filed 2018-03-08 | $112.00K derived: sum of 3 quarters · filed 2018-03-08 | $113.00K 10-K · filed 2018-03-08 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $112.00K derived: sum of 2 quarters · filed 2017-11-08 | $113.00K 10-Q · filed 2017-11-08 | $91.00K derived: sum of 4 quarters · filed 2018-03-08 |
| 2017-06-30 | $112.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $113.00K 10-Q · filed 2017-08-03 | $91.00K derived: sum of 3 quarters · filed 2018-03-08 | -$27.00K derived: sum of 4 quarters · filed 2018-03-08 |
| 2017-03-31 | $1.00K 10-Q · filed 2017-05-04 | -$21.00K derived: sum of 2 quarters · filed 2018-03-08 | -$139.00K derived: sum of 3 quarters · filed 2018-03-08 | -$139.00K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-12-31 | -$22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$140.00K derived: sum of 2 quarters · filed 2018-03-08 | -$140.00K derived: sum of 3 quarters · filed 2018-03-08 | -$139.00K 10-K · filed 2018-03-08 |
| 2016-09-30 | -$118.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$118.00K derived: sum of 2 quarters · filed 2017-11-08 | -$117.00K 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $1.00K 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $1.00K 10-Q · filed 2017-05-04 | |||
| 2015-12-31 | $1.40M 10-K · filed 2018-03-08 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $0.00 derived: sum of 2 quarters · filed 2017-03-16 | $102.00K 10-K · filed 2017-03-16 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $102.00K 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $102.00K 10-Q · filed 2015-08-10 | |||
| 2013-12-31 | $10.00K 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |